000 01612 a2200565 4500
005 20250514013721.0
264 0 _c19930303
008 199303s 0 0 eng d
022 _a0193-7758
040 _aNLM
_beng
_cNLM
100 1 _aShorr, Andrew F
245 0 0 _aAIDS and the FDA: an ethical case for limiting patient access to new medical therapies.
_h[electronic resource]
260 _bIRB
_c
300 _a1-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcquired Immunodeficiency Syndrome
650 0 4 _aAltruism
650 0 4 _aBeneficence
650 0 4 _aComplementary Therapies
650 0 4 _aDecision Making
650 0 4 _aDrugs, Investigational
650 0 4 _aEthics
650 0 4 _aFederal Government
650 0 4 _aFreedom
650 0 4 _aGovernment
650 0 4 _aGovernment Regulation
650 0 4 _aHIV Seropositivity
650 0 4 _aHuman Experimentation
650 0 4 _aHuman Rights
650 0 4 _aHumans
650 0 4 _aInformation Dissemination
650 0 4 _aInformation Services
650 0 4 _aInformed Consent
650 0 4 _aInsurance, Health
650 0 4 _aMental Competency
650 0 4 _aPaternalism
650 0 4 _aPatient Care
650 0 4 _aPatients
650 0 4 _aPersonal Autonomy
650 0 4 _aPolicy Making
650 0 4 _aPolitics
650 0 4 _aRisk
650 0 4 _aRisk Assessment
650 0 4 _aSocial Control, Formal
650 0 4 _aSocial Justice
650 0 4 _aTerminally Ill
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
773 0 _tIRB
_gvol. 14
_gno. 4
_gp. 1-5
999 _c11569620
_d11569620